Ciprofloxacin Contraindications and Precautions

Relative Contraindications and High-Risk Populations

The American Geriatrics Society identifies ciprofloxacin as potentially inappropriate in older adults due to increased risks of tendinitis, tendon rupture, CNS disorders, and dangerous drug interactions, particularly when combined with warfarin, which increases bleeding risk, and theophylline, which increases the risk of toxicity 1
Ciprofloxacin should be avoided in elderly patients when safer alternatives exist, and reserved for multidrug-resistant infections with no other options, as it can cause adverse effects such as increased risk of bleeding when combined with warfarin, and increased risk of theophylline toxicity 1
The use of ciprofloxacin in pediatric patients under 18 years is restricted to specific serious infections, such as complicated urinary tract infections and post-exposure anthrax prophylaxis, due to the risk of musculoskeletal problems, including bone, joint, and tendon pain or swelling, and the potential for adverse effects on developing cartilage 2
When anthrax exposure is confirmed and the strain is penicillin-susceptible, ciprofloxacin should be switched to amoxicillin to complete therapy in pediatric patients, as recommended by the MMWR Recommendations and Reports 2

Ciprofloxacin is recommended for pregnant women only in life-threatening situations, such as anthrax exposure, where disease severity outweighs potential teratogenic risk, although the actual teratogenic risk remains unknown due to limited human data 3
For confirmed penicillin-susceptible anthrax, treatment should be switched to amoxicillin in pregnant women, as recommended by the MMWR Recommendations and Reports 3

Ciprofloxacin should be used with caution or avoided in patients taking medications that increase serum potassium, due to the risk of hyperkalemia, as recommended by the Praxis Medical Insights: Practical Summaries of Clinical Guidelines 1